CINCINNATI--(BUSINESS WIRE)--The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens founded Camargo Pharmaceutical Services to help companies gain approval — and market exclusivity — under 505(b)(2). Camargo will be celebrating both anniversaries at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Nov. 10–14, in San Antonio.
Help employers find you! Check out all the jobs and post your resume.
